Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
- Study Title
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
- Teva Identifier
- TVP1012-PK-10002
- ClinicalTrials.gov Identifier
- NCT01879748
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline | Drug: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 20 Years to 50 Years
- Trial Duration
- 06/01/2013 - 11/01/2013
- Phase
- Phase 1
